Some opportunities for immunotherapy in coronavirus infection
Here we review means of immunomodulatory therapy for coronavirus infection caused by SARS-CoV-2 (COVID-19). It has been appreciated that highly limited arsenal of relatively effective means and methods of prevention and treatment of the COVID-19 pandemic is available. The goal of our study was to an...
Saved in:
Main Authors: | V. S. Smirnov, Areg A. Totolian |
---|---|
Format: | article |
Language: | RU |
Published: |
Sankt-Peterburg : NIIÈM imeni Pastera
2020
|
Subjects: | |
Online Access: | https://doaj.org/article/54c9f36d33bd4b29beb0e3e5c4c777a2 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Innate immunity in coronavirus infection
by: V. S. Smirnov, et al.
Published: (2020) -
History of investigation and current classification of coronaviruses (<i>Nidovirales: Coronaviridae</i>)
by: M. Yu. Shchelkanov, et al.
Published: (2020) -
Persistent SARS-CoV-2-positive over 4 months in a COVID-19 patient with CHB
by: Li Wenyuan, et al.
Published: (2021) -
Middle East Respiratory Syndrome Coronavirus Nonstructural Protein 16 Is Necessary for Interferon Resistance and Viral Pathogenesis
by: Vineet D. Menachery, et al.
Published: (2017) -
Convalescent Plasma for the Treatment of Severe COVID-19
by: Franchini M, et al.
Published: (2021)